SavedAdd your journal

Journals / Turkish Journal of Hematology / 2007 / Cilt: 24 - Sayı: 2

The prevalence of factor V Leiden (1691G-A) and methylenetetrahydrofolate reductase C677T mutations in healthy newborns in Bursa, Turkey

Birol BAYTAN
Adalet Güneş MERAL
Yesim Özarda İLÇÖL
Ünsal GÜNAY
Pages
90–92
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

BAYTAN, B., MERAL, A. G., İLÇÖL, Y. Ö., GÜNAY, Ü. (2007). The prevalence of factor V Leiden (1691G-A) and methylenetetrahydrofolate reductase C677T mutations in healthy newborns in Bursa, Turkey. Turkish Journal of Hematology, Cilt: 24 - Sayı: 2, 90–92. https://ajindex.com/articles/413420

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998;133:777-81
  2. Andrew M, Monagle PT, Broker L. Thromboembolic complications during infancy and childhood. In: Andrew M, ed. Congenital Prothrombotic Disorders: Presentation During Infancy and Childhood. 1st ed. London: B.C. Decker Hamilton, 2000:51-102
  3. Brown K, Luddington R, Baglin T. Effect of the MTHFR C677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations. Br J Haematol 1998;103:42-4
  4. Balasa V, Gruppo RA. The relationship of mutation in the MTHFR, prothrombin and Pal-1 genes to the plasma level of homocysteine in children and adults. Thromb Haemost 1999;81:739-44
  5. Nowak-Göttle U, Strater R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphism of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of ischaemic stroke in childhood. Blood 1999;94:3678-82
  6. Ozbek U, Tangün Y. Frequency of factor V Leiden in Turkey. Int J Hematol 1996;64:291-2
  7. Akar N, Akar E, Dalgın G. Frequency of factor V 1691 G-A in the Turkish population. Thromb Haemost 1997;39:313-5
  8. Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1998;41:344-7
  9. Akar N, Akar E, Mısırlıoglu M, Avcu F, Yalçin A, Cin S. Search for genetic factors favoring thrombosis in Turkish population. Thromb Research 1998;79:79-82
  10. Balta G, Gurgey A. Methylenetetrahydrofolate reductase (MTHFR) 677 C-T mutation in Turkish patients with thrombosis. Turk J Pediatr 1999;41:197-9
  11. Akar N, Akar E, Dalgın G. Frequency of factor V 1691 G-A in the Turkish population. Thromb Haemost 1997;39:313-5
  12. Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1998;41:344-7
  13. Chaida C, Gialeraki A, Tsoukala C, Mandalaki T. Prevalence of FVQ506 mutation in Hellenic population. Thromb Haeamost 1996;76:124-8
  14. Boyanovsky B, Russev M, Ganev V, Penev M, Baleva M. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis. Blood Coagul Fibrinolysis 2001;12:639-42
  15. Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous th